EORTC – European Organisation for Research and Treatment of Cancer shared on LinkedIn:
“We are proud to see the EORTC Quality of Life Group (QLG) represented so strongly at ISOQOL 2026 next week in Prague.
QLG researchers will present 16 abstracts, including 6 oral presentations and 10 posters, covering ongoing research in:
- patient-reported outcomes (PROs),
- pediatric oncology,
- survivorship,
- questionnaire development
- and methodological advances in health-related quality of life (HRQoL) research.
Their work continues to support a more patient-centred approach to cancer research and care, helping ensure that patients’ experiences remain at the heart of clinical research.
Learn more about the QLG’s activities and presentations.”
Other articles about EORTC on OncoDaily.